Written By InpharmD Drug Information Fellow, Muna Said — Postpartum depression (PPD) is a mental health condition that affects women after childbirth, often leading to feelings of sadness, guilt, and worthlessness. Its consequences extend beyond the individual and can impact the maternal-infant bond along with child development.1 While existing treatments for PPD involve intravenous (IV) formulations, a groundbreaking shift…

Written By InpharmD Drug Information Pharmacist: Dena Homayouneih — Cirrhosis is a leading cause of mortality, responsible for over 29,000 deaths annually in the United States and one million deaths worldwide. It ranks as the 12th leading cause of mortality in the U.S. and globally 1, 2. Type 2 diabetes mellitus (T2DM) is a chronic disease that poses a…

Take a moment to get to know our current InpharmD fellows and what their experiences have been like so far! Name: Dena Homayounieh Pharmacy School: West Coast University Tell us a little bit about yourself! I am originally from Iran and currently reside in San Diego, California. I completed my undergraduate studies at York University in Toronto…

Take a moment to get to know our current InpharmD fellows and what their experiences have been like so far! Name: Joy Ugwuanyi Pharmacy School: The Ohio State University Tell us a little bit about yourself! I am an international student from Nigeria who came to the U.S. for college. I attended West Virginia State University where…

Take a moment to get to know our current InpharmD fellows and what their experiences have been like so far! Name: Larissa A. Melnyk Pharmacy School: Northeast Ohio Medical University (NEOMED) Tell us a little bit about yourself! I’m from Wellington, Ohio. Before attending NEOMED, I completed pre-requisite courses at Lorain County Community College and Cleveland State…

Written by Dylan Brown, PharmD — Drug Information Specialist, InpharmD Nearly 10 years ago when the first sodium glucose co-transporter-2 (SGLT2) inhibitor, canagliflozin (Invokana®), received approval by the FDA, there was hope that this groundbreaking new drug class would be the cure-all for type 2 diabetes. After the approval of…

InpharmD™ Clinical Literature Summaries — S4E2 — We’ve always had the occasional issue with medication shortages, and I don’t know about you… but ever since the pandemic started it seems like there’s a new shortage almost every week. We’ve been getting lots of questions on alternatives to oxytocin due to the ongoing shortage of this critical medication. …

InpharmD™ Clinical Literature Summaries — S4E1 — Welcome back for Season 4! We like to throw new twists at you guys each season, so here’s what we’ve got in store. When one clinician has a clinical question, there’s a 40% chance another clinician has that exact same question. …

“To know what you know and what you do not know, that is true knowledge” — Confucius — Misinformation can affect any profession — even healthcare, and pharmacy practice. Misinformation in healthcare has direct, harmful consequences and the COVID-19 pandemic has brought this directly into the spotlight. Health care is based on the scientific process which includes evolving evidence, new information, tests, and evaluations — all of which…